Research location
Guastalla
Italy
Advertisement
Research activity in Guastalla
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 11 trials and 11 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Guastalla
11 linked trials · page 1 of 1Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)NCT05512364 · 2023-12-15 · 1 site observation
RECRUITING
Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)NCT04227327 · 2020-01-07 · 1 site observation
TERMINATED
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer PatientsNCT05730647 · 2019-10-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Adjuvant Palbociclib in Elderly Patients With Breast CancerNCT03609047 · 2019-06-14 · 1 site observation
ACTIVE_NOT_RECRUITING
CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDONCT03227328 · 2017-08-02 · 1 site observation
COMPLETED
Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung CancerNCT02633189 · 2016-04-01 · 1 site observation
UNKNOWN
Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast CancerNCT02404051 · 2015-12-01 · 1 site observation
UNKNOWN
A Study of Liposomal Doxorubicin+Docetaxel+Trastuzumab+Metformin in Operable and Locally Advanced HER2 Positive Breast CancerNCT02488564 · 2014-12-17 · 1 site observation
COMPLETED
Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 TherapiesNCT02238509 · 2014-11-01 · 1 site observation
UNKNOWN
Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung CancerNCT01379976 · 2011-04-01 · 1 site observation
TERMINATED
Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer PatientsNCT01885013 · 2010-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.